Search Results

Viewing Page 1 of 1 | Showing results 1 - 2 of 2

Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy (maintenance of remission) and safety of etrolizumab compared with placebo in patients with moderate to severe active ulcerative colitis who are naive to TNF inhibitors

To participate in a Phase III, randomized, double-blind, placebo-controlled multicenter study of etrolizumab for ulcerative colitis, please contact...
Nimisha K. Parekh, MD

UC Irvine Medical Center

Questionnaire for the Migrant Inflammatory Bowel Disease (IBD) Microbiome Analysis Study (MIMAS)

This clinical trial at UCI Health examines environmental risk factors for inflammatory bowel diseases. Call 714-456-7033.
Nimisha Parekh, MD

Online at